WMH and long-term outcomes in ischemic stroke: A systematic review and meta-analysis
- PMID: 30770431
- DOI: 10.1212/WNL.0000000000007142
WMH and long-term outcomes in ischemic stroke: A systematic review and meta-analysis
Abstract
Objective: To investigate the relationship between baseline white matter hyperintensities (WMH) in patients with ischemic stroke and long-term risk of dementia, functional impairment, recurrent stroke, and mortality.
Methods: Following the Meta-analysis of Observational Studies in Epidemiology and Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines (PROSPERO protocol: CRD42018092857), we systematically searched Medline and Scopus for cohort studies of ischemic stroke patients examining whether MRI- or CT-assessed WMH at baseline are associated with dementia, functional impairment, recurrent stroke, and mortality at 3 months or later poststroke. We extracted data and evaluated study quality with the Newcastle-Ottawa scale. We pooled relative risks (RR) for the presence and severity of WMH using random-effects models.
Results: We included 104 studies with 71,298 ischemic stroke patients. Moderate/severe WMH at baseline were associated with increased risk of dementia (RR 2.17, 95% confidence interval [CI] 1.72-2.73), cognitive impairment (RR 2.29, 95% CI 1.48-3.54), functional impairment (RR 2.21, 95% CI 1.83-2.67), any recurrent stroke (RR 1.65, 95% CI 1.36-2.01), recurrent ischemic stroke (RR 1.90, 95% CI 1.26-2.88), all-cause mortality (RR 1.72, 95% CI 1.47-2.01), and cardiovascular mortality (RR 2.02, 95% CI 1.44-2.83). The associations followed dose-response patterns for WMH severity and were consistent for both MRI- and CT-defined WMH. The results remained stable in sensitivity analyses adjusting for age, stroke severity, and cardiovascular risk factors, in analyses of studies scoring high in quality, and in analyses adjusted for publication bias.
Conclusions: Presence and severity of WMH are associated with substantially increased risk of dementia, functional impairment, stroke recurrence, and mortality after ischemic stroke. WMH may aid clinical prognostication and the planning of future clinical trials.
© 2019 American Academy of Neurology.
Comment in
-
Reader response: WMH and long-term outcomes in ischemic stroke: A systematic review and meta-analysis.Neurology. 2020 Mar 3;94(9):410-411. doi: 10.1212/WNL.0000000000009042. Neurology. 2020. PMID: 32123058 No abstract available.
-
Author response: WMH and long-term outcomes in ischemic stroke: A systematic review and meta-analysis.Neurology. 2020 Mar 3;94(9):411. doi: 10.1212/WNL.0000000000009043. Neurology. 2020. PMID: 32123059 No abstract available.
Similar articles
-
Risk factors for cognitive impairment and dementia after stroke: a systematic review and meta-analysis.Lancet Healthy Longev. 2024 Jan;5(1):e31-e44. doi: 10.1016/S2666-7568(23)00217-9. Epub 2023 Dec 12. Lancet Healthy Longev. 2024. PMID: 38101426
-
White matter hyperintensity burden and functional outcomes in acute ischemic stroke patients after mechanical thrombectomy: A systematic review and meta-analysis.Neuroimage Clin. 2024;41:103549. doi: 10.1016/j.nicl.2023.103549. Epub 2023 Dec 7. Neuroimage Clin. 2024. PMID: 38071889 Free PMC article. Review.
-
White matter hyperintensities are an independent predictor of cognitive decline 3 years following first-ever stroke-results from the PROSCIS-B study.J Neurol. 2023 Mar;270(3):1637-1646. doi: 10.1007/s00415-022-11481-5. Epub 2022 Dec 6. J Neurol. 2023. PMID: 36471099 Free PMC article.
-
White matter hyperintensities and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 36 prospective studies.Neurosci Biobehav Rev. 2021 Jan;120:16-27. doi: 10.1016/j.neubiorev.2020.11.007. Epub 2020 Nov 11. Neurosci Biobehav Rev. 2021. PMID: 33188821 Review.
-
Impaired renal function is associated with brain atrophy and poststroke cognitive decline.Neurology. 2016 May 24;86(21):1996-2005. doi: 10.1212/WNL.0000000000002699. Epub 2016 Apr 27. Neurology. 2016. PMID: 27164678 Free PMC article.
Cited by
-
Cerebral white matter hyperintensities indicate severity and progression of coronary artery calcification.Sci Rep. 2024 Feb 26;14(1):4664. doi: 10.1038/s41598-024-55305-0. Sci Rep. 2024. PMID: 38409473 Free PMC article.
-
The analysis of association between single features of small vessel disease and stroke outcome shows the independent impact of the number of microbleeds and presence of lacunes.Sci Rep. 2024 Feb 10;14(1):3402. doi: 10.1038/s41598-024-53500-7. Sci Rep. 2024. PMID: 38336856 Free PMC article.
-
Lifetime influences on imaging markers of adverse brain health and vascular disease.Cereb Circ Cogn Behav. 2023 Dec 15;6:100194. doi: 10.1016/j.cccb.2023.100194. eCollection 2024. Cereb Circ Cogn Behav. 2023. PMID: 38292018 Free PMC article.
-
Genetic Predisposition for White Matter Hyperintensities and Risk of Mild Cognitive Impairment and Alzheimer's Disease: Results from the HELIAD Study.Curr Issues Mol Biol. 2024 Jan 22;46(1):934-947. doi: 10.3390/cimb46010060. Curr Issues Mol Biol. 2024. PMID: 38275674 Free PMC article.
-
Effects of the royal jelly consumption on post-stroke complications in patients with ischemic stroke: results of a randomized controlled trial.Front Nutr. 2024 Jan 8;10:1227414. doi: 10.3389/fnut.2023.1227414. eCollection 2023. Front Nutr. 2024. PMID: 38260068 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical